{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T02:41:15Z","timestamp":1791600075930,"version":"4.3.4"},"reference-count":34,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2010,9,1]],"date-time":"2010-09-01T00:00:00Z","timestamp":1283299200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,3]],"date-time":"2019-12-03T00:00:00Z","timestamp":1575331200000},"content-version":"vor","delay-in-days":3380,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Oncology"],"published-print":{"date-parts":[[2010,9]]},"DOI":"10.1093\/annonc\/mdq038","type":"journal-article","created":{"date-parts":[[2010,3,12]],"date-time":"2010-03-12T01:25:51Z","timestamp":1268357151000},"page":"1786-1793","source":"Crossref","is-referenced-by-count":137,"title":["Chemotherapy of advanced small-bowel adenocarcinoma: a multicenter AGEO study"],"prefix":"10.1016","volume":"21","author":[{"given":"A.","family":"Zaanan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Costes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Gauthier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Malka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Locher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Mitry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Tougeron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Lecomte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.-M.","family":"Gornet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Sobhani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Moulin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Afchain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Ta\u00efeb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Bonnetain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Aparicio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1093\/annonc\/mdq038_bb0010","first-page":"529","article-title":"An overview of adenocarcinoma of the small intestine","volume":"11","author":"Neugut","year":"1997","journal-title":"Oncology (Williston Park)"},{"key":"10.1093\/annonc\/mdq038_bb0015","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1038\/sj.bjc.6690541","article-title":"Descriptive epidemiology of small intestinal malignancies: the German Cancer Registry experience","volume":"80","author":"Stang","year":"1999","journal-title":"Br J Cancer"},{"key":"10.1093\/annonc\/mdq038_bb0020","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1093\/ije\/25.4.722","article-title":"A population-based study of the incidence of malignant small bowel tumours: SEER, 1973\u20131990","volume":"25","author":"Chow","year":"1996","journal-title":"Int J Epidemiol"},{"key":"10.1093\/annonc\/mdq038_bb0025","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1001\/archsurg.142.3.229","article-title":"Small-bowel tumors: epidemiologic and clinical characteristics of 1260 cases from the Connecticut tumor registry","volume":"142","author":"Hatzaras","year":"2007","journal-title":"Arch Surg"},{"key":"10.1093\/annonc\/mdq038_bb0030","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/S0889-8553(02)00010-9","article-title":"Celiac disease and other precursors to small-bowel malignancy","volume":"31","author":"Green","year":"2002","journal-title":"Gastroenterol Clin North Am"},{"key":"10.1093\/annonc\/mdq038_bb0035","doi-asserted-by":"crossref","first-page":"2693","DOI":"10.1002\/(SICI)1097-0142(19991215)86:12<2693::AID-CNCR14>3.0.CO;2-U","article-title":"The American College of Surgeons Commission on Cancer and the American Cancer Society. Adenocarcinoma of the small bowel: review of the National Cancer Data Base, 1985\u20131995","volume":"86","author":"Howe","year":"1999","journal-title":"Cancer"},{"key":"10.1093\/annonc\/mdq038_bb0040","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1002\/cncr.20404","article-title":"Adenocarcinoma of the small bowel: presentation, prognostic factors, and outcome of 217 patients","volume":"101","author":"Dabaja","year":"2004","journal-title":"Cancer"},{"key":"10.1093\/annonc\/mdq038_bb0045","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1001\/archsurg.137.5.564","article-title":"Primary cancers of the small bowel: analysis of prognostic factors and results of surgical management","volume":"137","author":"Talamonti","year":"2002","journal-title":"Arch Surg"},{"key":"10.1093\/annonc\/mdq038_bb0050","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.clon.2006.12.001","article-title":"Chemotherapy in small bowel adenocarcinoma: 10-year experience of the British Columbia Cancer Agency","volume":"19","author":"Czaykowski","year":"2007","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"10.1093\/annonc\/mdq038_bb0055","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1097\/01. coc.0000214931.01062.01","article-title":"Natural history and chemotherapy effectiveness for advanced adenocarcinoma of the small bowel: a retrospective review of 113 cases","volume":"29","author":"Fishman","year":"2006","journal-title":"Am J Clin Oncol"},{"key":"10.1093\/annonc\/mdq038_bb0060","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1038\/bjc.1998.523","article-title":"The Royal Marsden experience of a small bowel adenocarcinoma treated with protracted venous infusion 5-fluorouracil","volume":"78","author":"Crawley","year":"1998","journal-title":"Br J Cancer"},{"key":"10.1093\/annonc\/mdq038_bb0065","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1634\/theoncologist.10-2-132","article-title":"Phase II study of 5-fluorouracil, doxorubicin, and mitomycin C for metastatic small bowel adenocarcinoma","volume":"10","author":"Gibson","year":"2005","journal-title":"Oncologist"},{"key":"10.1093\/annonc\/mdq038_bb0070","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1002\/1097-0142(19840101)53:1<23::AID-CNCR2820530106>3.0.CO;2-U","article-title":"Chemotherapy for primary adenocarcinoma of the small bowel","volume":"53","author":"Jigyasu","year":"1984","journal-title":"Cancer"},{"key":"10.1093\/annonc\/mdq038_bb0075","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1159\/000089678","article-title":"Combination chemotherapy in advanced small bowel adenocarcinoma","volume":"69","author":"Locher","year":"2005","journal-title":"Oncology"},{"key":"10.1093\/annonc\/mdq038_bb0080","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1002\/cncr.23822","article-title":"Chemotherapy with 5-fluorouracil and a platinum compound improves outcomes in metastatic small bowel adenocarcinoma","volume":"113","author":"Overman","year":"2008","journal-title":"Cancer"},{"key":"10.1093\/annonc\/mdq038_bb0085","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1038\/nrc2167","article-title":"The resurgence of platinum-based cancer chemotherapy","volume":"7","author":"Kelland","year":"2007","journal-title":"Nat Rev Cancer"},{"key":"10.1093\/annonc\/mdq038_bb0090","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1016\/0959-8049(93)90073-O","article-title":"Oxaliplatin activity against metastatic colorectal cancer. A phase II study of 5-day continuous venous infusion at circadian rhythm modulated rate","volume":"29A","author":"Levi","year":"1993","journal-title":"Eur J Cancer"},{"key":"10.1093\/annonc\/mdq038_bb0095","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1002\/1097-0142(19810101)47:1<207::AID-CNCR2820470134>3.0.CO;2-6","article-title":"Reporting results of cancer treatment","volume":"47","author":"Miller","year":"1981","journal-title":"Cancer"},{"key":"10.1093\/annonc\/mdq038_bb0100","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1200\/JCO.1997.15.2.808","article-title":"Randomized trial comparing monthly low-dose leucovorin and fluorouracil bolus with bimonthly high-dose leucovorin and fluorouracil bolus plus continuous infusion for advanced colorectal cancer: a French intergroup study","volume":"15","author":"de Gramont","year":"1997","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdq038_bb0105","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/S0140-6736(00)02034-1","article-title":"Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial","volume":"355","author":"Douillard","year":"2000","journal-title":"Lancet"},{"key":"10.1093\/annonc\/mdq038_bb0110","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1093\/annonc\/mdh182","article-title":"Combination of folinic acid, 5-fluorouracil bolus and infusion, and cisplatin (LV5FU2-P regimen) in patients with advanced gastric or gastroesophageal junction carcinoma","volume":"15","author":"Mitry","year":"2004","journal-title":"Ann Oncol"},{"key":"10.1093\/annonc\/mdq038_bb0115","doi-asserted-by":"crossref","first-page":"2938","DOI":"10.1200\/JCO.2000.18.16.2938","article-title":"Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer","volume":"18","author":"de Gramont","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdq038_bb0120","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","article-title":"Nonparametric estimation from incomplete observations","volume":"53","author":"Kaplan","year":"1958","journal-title":"J Am Statist Assoc"},{"key":"10.1093\/annonc\/mdq038_bb0125","first-page":"163","article-title":"Evaluation of survival data and two new rank order statistics arising in its consideration","volume":"50","author":"Mantel","year":"1966","journal-title":"Cancer Chemother Rep"},{"key":"10.1093\/annonc\/mdq038_bb0130","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.2517-6161.1972.tb00899.x","article-title":"Regression models and life-tables","volume":"B34","author":"Cox","year":"1972","journal-title":"J R Stat Soc"},{"key":"10.1093\/annonc\/mdq038_bb0135","doi-asserted-by":"crossref","first-page":"340","DOI":"10.2105\/AJPH.79.3.340","article-title":"Modeling and variable selection in epidemiologic analysis","volume":"79","author":"Greenland","year":"1989","journal-title":"Am J Public Health"},{"key":"10.1093\/annonc\/mdq038_bb0140","doi-asserted-by":"crossref","first-page":"2598","DOI":"10.1200\/JCO.2008.19.7145","article-title":"Phase II study of capecitabine and oxaliplatin for advanced adenocarcinoma of the small bowel and ampulla of Vater","volume":"27","author":"Overman","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdq038_bb0145","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1200\/JCO.1990.8.2.313","article-title":"Randomized study of continuous infusion fluorouracil versus fluorouracil plus cisplatin in patients with metastatic colorectal cancer","volume":"8","author":"Kemeny","year":"1990","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdq038_bb0150","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1056\/NEJMoa073149","article-title":"Capecitabine and oxaliplatin for advanced esophagogastric cancer","volume":"358","author":"Cunningham","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1093\/annonc\/mdq038_bb0155","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1200\/JCO.1997.15.1.261","article-title":"Randomized trial comparing epirubicin, cisplatin, and fluorouracil versus fluorouracil, doxorubicin, and methotrexate in advanced esophagogastric cancer","volume":"15","author":"Webb","year":"1997","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdq038_bb0160","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1056\/NEJMoa032691","article-title":"Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer","volume":"350","author":"Hurwitz","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1093\/annonc\/mdq038_bb0165","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1056\/NEJMoa0805019","article-title":"Cetuximab and chemotherapy as initial treatment for metastatic colorectal cancer","volume":"360","author":"Van Cutsem","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1093\/annonc\/mdq038_bb0170","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1200\/JCO.2007.12.5906","article-title":"KRAS mutations as an independent prognostic factor in patients with advanced colorectal cancer treated with cetuximab","volume":"26","author":"Lievre","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdq038_bb0175","first-page":"293","article-title":"Overexpression of p53 protein and point mutation of K-ras genes in primary carcinoma of the small intestine","volume":"9","author":"Nishiyama","year":"2002","journal-title":"Oncol Rep"}],"container-title":["Annals of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419400616?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419400616?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/annonc\/article-pdf\/21\/9\/1786\/340237\/mdq038.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T11:44:07Z","timestamp":1739965447000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923753419400616"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,9]]},"references-count":34,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2010,9]]}},"alternative-id":["S0923753419400616"],"URL":"https:\/\/doi.org\/10.1093\/annonc\/mdq038","relation":{},"ISSN":["0923-7534"],"issn-type":[{"value":"0923-7534","type":"print"}],"subject":[],"published":{"date-parts":[[2010,9]]}}}